Nucleating Agent Blend for Polyolefin Shrinkage Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current nucleating agents for polypropylene in plastic manufacturing often result in excessive shrinkage and warpage due to anisotropic shrinkage, which complicates achieving the desired dimensional specifications and cycle time reduction in injection molding processes.

Innovation Solution

A blend of bicyclo[2.2.1]heptane dicarboxylate salt (Hyperform® HPN-68L) and calcium metal salt (Hyperform® HPN-20E) is used as a nucleating agent composition to reduce shrinkage and maintain high crystallization temperatures, improving isotropic shrinkage and mechanical properties in polyolefin articles.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Temperature

If conventional nucleating agents are used to achieve high crystallization temperatures and cycle time reduction, then crystallization temperature increases and cycle time decreases, but shrinkage and warpage increase due to anisotropic shrinkage

Engineering Contradiction:
Improvecrystallization temperatureVSAvoiddimensional specifications
Core Design Contradiction:
TemperatureVSManufacturing precision

Solution Approach 1:

The patent combines two different nucleating agents (a carboxylic acid salt compound and a phosphate-containing salt compound) into a single blended composition. This merging allows the composition to achieve high crystallization temperature (from the carboxylic acid salt) while simultaneously reducing anisotropic shrinkage and warpage (from the phosphate-containing salt), thereby resolving the contradiction between temperature improvement and dimensional precision maintenance.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The nucleating agent composition is a composite material consisting of multiple chemical compounds with different functionalities. The carboxylic acid salt component provides high crystallization temperature, while the phosphate-containing salt component controls shrinkage anisotropy. This composite approach allows simultaneous optimization of both crystallization temperature and dimensional stability, resolving the technical contradiction.

Inventive Principle:
Principle #40Composite materials

2Productivity

If nucleating agents are added to reduce cycle time through higher crystallization temperature, then cycle time is reduced, but shrinkage increases causing parts to be out of dimensional specifications

Engineering Contradiction:
Improvecycle timeVSAvoiddimensional specifications
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The blended nucleating agent composition merges the cycle time reduction benefit (from high Tc carboxylic acid salt) with the dimensional stability benefit (from shrinkage-controlling phosphate salt). This allows simultaneous achievement of both productivity improvement and precision maintenance, resolving the contradiction between cycle time reduction and dimensional specification compliance.

Inventive Principle:
Principle #5Merging (Combining)

3Strength

If phosphate ester salts are used to increase stiffness, then flexural modulus increases, but anisotropic shrinkage causes warpage

Engineering Contradiction:
Improveflexural modulusVSAvoidwarpage
Core Design Contradiction:
StrengthVSShape

Solution Approach 1:

The patent merges the stiffness-enhancing property of phosphate ester salts with the warpage-reducing property of carboxylic acid salts. The phosphate component provides high flexural modulus while the carboxylic acid component counteracts the anisotropic shrinkage that would otherwise cause warpage. This blending resolves the contradiction between strength improvement and shape stability.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The blend significantly reduces shrinkage and warpage while maintaining high crystallization temperatures, allowing for efficient cycle time reduction and improved mechanical properties, such as flexural modulus, in injection-molded parts.

Implementation Method 1

enables the polymer to achieve a significant cycle time reduction in the molding process compared to using non-nucleated polypropylene... by inducing in the resin a higher Tc (crystallization temperature)

Methodology Applied
Scientific EffectCrystallization: Crystallisation

Implementation Method 2

Nucleating agents that adjust the shrinkage to be more isotropic, i.e. shrinkage in the machine direction becoming equal to shrinkage in the transverse direction are favorable for reducing cycle time

Methodology Applied
Scientific EffectNucleation: Nucleation

Data Source

PatentUS7659336B2Nucleating agent additive compositions and methods
Publication Date: 2010.02.09 MILLIKEN & CO
  • US7659336B2 patent drawing
  • US7659336B2 patent drawing
  • US7659336B2 patent drawing

AI summary

A blend of two different compounds may be applied together to form a nucleating agent additive composition. This additive composition is useful as an additive in thermoplastics, polyolefins and/or polymer resins. A blend of a bicyclo[2.2.1]heptane dicarboxylate salt and a dicarboxylate calcium metal salt provide useful and beneficial physical property effects in molded polymeric articles in terms of shrinkage and crystallization temperature of polymer resin compositions.